JUL 17·SEC EDGARLow
Elsbernd Brian sold (to issuer) $7.6M of CPRX
Elsbernd Brian (Chief Legal Officer) sold (to issuer) 242,501 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($7.64M total) on 2026-07-15.
StockDelisted · Aug 2026NASDAQ · US · USDHealthcare · Biotechnology
$CPRX
CATALYST PHARMACEUTICALS, INC.
Price · $CPRXvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $CPRX in the last 7 days.
Insider · 30dAll trades →
No SEC Form 4 filings for $CPRX in the last 30 days.
See all $CPRX insider activity →Top stories · $CPRXMore →
JUL 17·SEC EDGAR
Tierney David S sold (to issuer) $12.1M of CPRX
Tierney David S sold (to issuer) 383,314 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($12.07M total) on 2026-07-15.
JUL 17·SEC EDGAR
Miller Steve sold (to issuer) $34.5M of CPRX
Miller Steve (Chief Op. & Scientific Officer) sold (to issuer) 1,093,803 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($34.45M total) on 2026-07-15.
CPRX sentiment & insider activity
What's driving CPRX
This is a routine insider sale to the issuer (buyback participation style), not a new operating or regulatory catalyst.
This is a large insider sale to the issuer, but it is not accompanied by any new operational or regulatory catalyst in the filing.
Large insider sale to issuer is a liquidity event, not necessarily a negative fundamental signal, but it can affect near-term sentiment.
This is a routine insider sale to the issuer (buyback participation style), with no stated 10b5-1 plan and a post-transaction zero-share holding.
Large director sale to the issuer via Form 4 is a near-term sentiment datapoint, but it is not a fundamental operating update.
alphai scores every news story that mentions CPRX with an AI model for sentiment and relevance, and aggregates insider trades from CATALYST PHARMACEUTICALS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $CPRX
Score
Elsbernd Brian sold (to issuer) $7.6M of CPRX
Elsbernd Brian (Chief Legal Officer) sold (to issuer) 242,501 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($7.64M total) on 2026-07-15.
1 min readTierney David S sold (to issuer) $12.1M of CPRX
Tierney David S sold (to issuer) 383,314 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($12.07M total) on 2026-07-15.
1 min readMiller Steve sold (to issuer) $34.5M of CPRX
Miller Steve (Chief Op. & Scientific Officer) sold (to issuer) 1,093,803 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($34.45M total) on 2026-07-15.
1 min readThompson Tamar sold (to issuer) $119K of CPRX
Thompson Tamar sold (to issuer) 3,773 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($0.12M total) on 2026-07-15.
1 min readMCENANY PATRICK J sold (to issuer) $131.4M of CPRX
MCENANY PATRICK J sold (to issuer) 4,171,559 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($131.40M total) on 2026-07-15.
2 min readDENKHAUS DONALD A sold (to issuer) $15.7M of CPRX
DENKHAUS DONALD A sold (to issuer) 498,773 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($15.71M total) on 2026-07-15.
1 min readDel Carmen Jeffrey sold (to issuer) $452K of CPRX
Del Carmen Jeffrey (Chief Commercial Officer) sold (to issuer) 14,337 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($0.45M total) on 2026-07-15.
1 min readSundaram Preethi sold (to issuer) $1.7M of CPRX
Sundaram Preethi (Chief Strategy Officer) sold (to issuer) 54,804 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($1.73M total) on 2026-07-15.
2 min readDaly Richard J sold (to issuer) $8.5M of CPRX
Daly Richard J (President and CEO) sold (to issuer) 271,266 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($8.54M total) on 2026-07-15.
2 min readHarper Molly sold (to issuer) $116K of CPRX
Harper Molly sold (to issuer) 3,694 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($0.12M total) on 2026-07-15.
1 min read